Literature DB >> 1992237

Warm heart surgery.

S V Lichtenstein1, K A Ashe, H el Dalati, R J Cusimano, A Panos, A S Slutsky.   

Abstract

Hypothermia is widely acknowledged to be the fundamental component of myocardial protection during cardiac operations. Although it prolongs the period of ischemic arrest by reducing oxygen demands, hypothermia is associated with a number of major disadvantages, including its detrimental effects on enzymatic function, energy generation, and cellular integrity. We hypothesized that the ideal protected state of the heart would be electromechanically arrested and perfused with blood, that is, aerobic arrest. Under these conditions the fundamental need for hypothermia becomes questionable. We have developed a novel approach to myocardial protection during cardiac operations based on these concepts, in which the chemically arrested heart is perfused continuously with blood and maintained at 37 degrees C. In 121 consecutive coronary bypass procedures we have compared this approach with a historical cohort of 133 consecutive patients treated with hypothermic cardioplegia. Perioperative myocardial infarction was significantly less prevalent (1.7% versus 6.8%; p less than 0.05) in the warm cardioplegic group, as was the use of the intraaortic balloon pump (0.9% versus 9.0%; p less than 0.005) and the prevalence of low output syndrome (13.5% versus 3.3%; p less than 0.005). Cardiac output immediately after bypass was significantly higher than before bypass (3.1 +/- 0.9 versus 4.9 +/- 1.0 L/min; p less than 0.001) only in the warm cardioplegia group. Furthermore, the heartbeat in 99.2% of patients treated with continuous warm cardioplegia converted to normal sinus rhythm spontaneously after removal of the aortic crossclamp compared with only 10.5% of the hypothermic group. The time from removal of the aortic crossclamp to discontinuation of cardiopulmonary bypass (i.e., reperfusion time) was significantly shorter in the warm cardioplegia group (11 +/- 4.3 versus 27 +/- 5.6 minutes; p less than 0.001). Our results suggest that continuous normothermic blood cardioplegia is safe and effective. Conceptually, this represents a new approach to the problem of maintaining excellent myocardial preservation during cardiac operations.

Entities:  

Mesh:

Year:  1991        PMID: 1992237

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  31 in total

1.  Application of a manifold system for temporary reperfusion during proximal anastomoses in conventional coronary bypass surgery.

Authors:  K Hisatomi; Y Moriyama; G Yotsumoto; A Kobayashi; R Toda; S Shimokawa; A Taira
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Coronary artery bypass grafting in dialysis patients.

Authors:  H Tanaka; K Suzuki; T Narisawa; T Ookura; Y Kamio; S Suzuki; A Kitami; T Suzuki; T Takaba
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-11

3.  Myocardial protection: the rebirth of potassium-based cardioplegia.

Authors:  M S Shiroishi
Journal:  Tex Heart Inst J       Date:  1999

4.  Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics.

Authors:  Hiroshi Yamamoto; Fumio Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-23

5.  Valve replacement under retrograde warm-blood cardioplegia. Results in 287 patients.

Authors:  G A Tolis; N Sfyras; G Astras; G Georgiou
Journal:  Tex Heart Inst J       Date:  1998

6.  Effects of calcium in continuous cardioplegia on myocardial protection.

Authors:  N Takemoto; H Kuroda; Y Nakamura; T Ichiba; N Matsuda; Y Ashida; T Hamasaki; Y Hara; S Ishiguro; T Mori
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

7.  [Clinical benefits of normothermic cardiopulmonary bypass on postoperative systemic metabolism].

Authors:  S Moriyama; J Utoh; K Okamoto; T Hirata; R Kunitomo; M Tanaka; N Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-02

Review 8.  Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam.

Authors:  Kosmas Tsakiridis; Andreas Mpakas; George Kesisis; Stamatis Arikas; Michael Argyriou; Stavros Siminelakis; Paul Zarogoulidis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Eirini Sarika; Ioanna Katamoutou; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

9.  Optimal temperature of continuous lidocaine perfusion for the heart preservation.

Authors:  Mitsuru Asano; Koichi Inoue; Susumu Ando; Atsushi Bito; Yasuhiro Shiojiri; Makoto Yamada; Toshihiro Takaba
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-01

Review 10.  Strategies to prevent intraoperative lung injury during cardiopulmonary bypass.

Authors:  Efstratios E Apostolakis; Efstratios N Koletsis; Nikolaos G Baikoussis; Stavros N Siminelakis; Georgios S Papadopoulos
Journal:  J Cardiothorac Surg       Date:  2010-01-11       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.